The effect of laparoscopic gastric bypass on dyslipidemia in severely obese patients: A 5-year follow-up analysis

Obesity Surgery

Volumn 24, Issue 4, 2014, Pages 549-553

  Ties, Jill S ^a   Zlabek, Jonathan A ^b   Kallies, Kara J ^a   Al Hamadini, Mohammed ^a   Kothari, Shanu N ^b  

^a GUNDERSEN LUTHERAN MEDICAL CENTER   (United States)

^b GUNDERSEN HEALTH SYSTEM   (United States)

Author keywords

Cholesterol; Dyslipidemias; Gastric bypass; Hypercholesterolemia; Lipids; Morbid obesity; Roux en Y

Indexed keywords

AGENTS AFFECTING LIPID METABOLISM; CHOLESTEROL; FIBRIC ACID DERIVATIVE; HIGH DENSITY LIPOPROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN; NICOTINIC ACID; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; DRUG THERAPY; DYSLIPIDEMIA; FEMALE; FOLLOW UP; HUMAN; LAPAROSCOPIC SURGERY; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OBESITY; PRIORITY JOURNAL; ROUX Y ANASTOMOSIS; STOMACH BYPASS; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; COMORBIDITY; DYSLIPIDEMIAS; LAPAROSCOPY; MIDDLE AGED; OBESITY, MORBID; POSTOPERATIVE PERIOD; TREATMENT OUTCOME;

ADULT; BODY MASS INDEX; COMORBIDITY; DYSLIPIDEMIAS; FEMALE; FOLLOW-UP STUDIES; GASTRIC BYPASS; HUMANS; LAPAROSCOPY; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; OBESITY, MORBID; POSTOPERATIVE PERIOD; TREATMENT OUTCOME;

EID: 84898041676     PISSN: 09608923     EISSN: 17080428     Source Type: Journal    
DOI: 10.1007/s11695-013-1120-y     Document Type: Article

References (23)

1. Hsia J, Rodabough R, Rosal MC, et al. Compliance with National Cholesterol Education Program dietary and lifestyle guidelines among older women with self-reported hypercholesterolemia: the Women's Health Initiative. Am J Med. 2002;113(5):384-92. PMID 12401533.
2. Arterburn D, Schauer DP, Wise RE, et al. Change in predicted 10-year cardiovascular risk following laparoscopic Roux-en-Y gastric bypass surgery. Obes Surg. 2009;19(2):184-9.
3. Dumon KR, Murayama KM. Bariatric surgery outcomes. Surg Clin North Am. 2011;91(6):1313-38. PMID 22054156.
4. Smith BR, Schauer P, Nguyen NT. Surgical approaches to the treatment of obesity: bariatric surgery. Endocrinol Metab Clin North Am. 2008;37(4):943-64. PMID 19026941.
5. Poirier P, Cornier MA, Mazzone T, et al. Bariatric surgery and cardiovascular risk factors: a scientific statement from the American Heart Association. Circulation. 2011;123(15):1683-701. PMID 21403092.
6. Chan DC, Barrett HP, Watts GF. Dyslipidemia in visceral obesity: mechanisms, implications, and therapy. Am J Cardiovasc Drugs. 2004;4(4):227-46. PMID 15285698.
7. Henkin Y, Shai I, Zuk R, et al. Dietary treatment of hypercholesterolemia: do dietitians do it better? A randomized, controlled trial. Am J Med. 2000;109(7):549-55. PMID 11063956.
8. Dallal RM, Hatalski A, Trang A, et al. Longitudinal analysis of cardiovascular parameters after gastric bypass surgery. Surg Obes Relat Dis. 2012;8(6):703-9.
9. Gleysteen JJ. Results of surgery: long-term effects on hyperlipidemia. Am J Clin Nutr. 1992;55(2 Suppl):591S-3S. PMID 1733134.
10. 2) Indian patients with type 2 diabetes mellitus. Surg Obes Relat Dis. 2013;9(3):370-8.
11. Zlabek JA, Grimm MS, Larson CJ, et al. The effect of laparoscopic gastric bypass surgery on dyslipidemia in severely obese patients. Surg Obes Relat Dis. 2005;1(6):537-42.
12. NIH conference. NIH conference. Gastrointestinal surgery for severe obesity. Consensus Development Conference Panel. Ann Intern Med. 1991;115(12):956-61.
13. Kothari SN, Boyd WC, Larson CA, et al. Training of a minimally invasive bariatric surgeon: are laparoscopic fellowships the answer? Obes Surg. 2005;15(3):323-9. PMID 15832432.
14. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2001) Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285(19):2486-97. PMID 11368702
15. Jamal M, Wegner R, Heitshusen D, et al. Resolution of hyperlipidemia follows surgical weight loss in patients undergoing Roux-en-Y gastric bypass surgery: a 6-year analysis of data. Surg Obes Relat Dis. 2011;7(4):473-9.
16. Adams TD, Davidson LE, Litwin SE, et al. Health benefits of gastric bypass surgery after 6 years. JAMA. 2012;308(11):1122-31. PMID 22990271.
17. Sjöström L, Lindroos AK, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351(26):2683-93.
18. Nguyen NT, Varela E, Sabio A, et al. Resolution of hyperlipidemia after laparoscopic Roux-en-Y gastric bypass. J Am Coll Surg. 2006;203(1):24-9.
19. Sever PS, Dahlöf B, Poulter NR, et al. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial - Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial. Lancet. 2003;361(9364):1149-58.
20. Sacks FM, Pfeffer MA, Moye LA, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N Engl J Med. 1996;335(14):1001-9. PMID 8801446.
21. Anonymous (1994) Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 344(8934):1383-1389. PMID 7968073
22. Scopinaro N, Marinari GM, Camerini GB, et al. Specific effects of biliopancreatic diversion on the major components of metabolic syndrome: a long-term follow-up study. Diabetes Care. 2005;28(10):2406-11. PMID 16186271.
23. Rössner S, Björvell H. Early and late effects of weight loss on lipoprotein metabolism in severe obesity. Atherosclerosis. 1987;64(2-3):125-30. PMID 3606709.